Chronic Obstructive Pulmonary Disease Clinical Trial
— IMPACTOfficial title:
Developing Personalised, Relative Intensity Physical Activity Thresholds for Accelerometer-Derived Measures of Physical Activity in COPD (IMPACT)
The aim of this observational study is to translate the principle of individualised exercise prescription into the evaluation of daily absolute and relative intensity physical activity. The main questions this study aims to answer are: - Phase 1: What does physical activity (intensity) mean to people with COPD? - Phase 2: Are there differences between time spent in absolute and relative physical activity for people with COPD? Phase 1 Participants will take part in semi-structured interview (30-45 minutes) about living with COPD and perceptions of physical activity and how they perceive intensity. This will also include photovoice and photo-elicitation. Demographic information will be recorded and participants will also complete several respiratory symptom questionnaires. Phase 2: Participants will take part in physical activity testing before and after pulmonary rehabilitation while wearing physical activity monitors. Demographic information will be recorded and participants will also complete several respiratory symptom and physical activity questionnaires. Participants will also wear the physical activity monitors for 8 days after the pre-testing sessions and after their final pulmonary rehabilitation class. Sub-study: Participants will be asked to take images of barriers during physical activity, facilitators during physical activity, feelings during physical activity and types of physical activity they take part in for 8 days after their final pulmonary rehabilitation class. Participants will then take part in a semi-structured interview about the images their have taken while doing physical activity.
Status | Recruiting |
Enrollment | 70 |
Est. completion date | September 1, 2025 |
Est. primary completion date | March 30, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years and older |
Eligibility | Phase 1: Inclusion Criteria: - Willing and able to provide informed consent for participation in the research. - The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria (Agustà et al., 2023). - Male or female, aged 40+ years - Able to communicate in written and spoken English. Exclusion Criteria: - Unable to provide valid informed consent. - Severe psychiatric disorders - Aged less than 40 years - Unable to understand written or spoken English. Phase 2: Inclusion Criteria: - Willing and able to provide informed consent for participation in the research. - The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria. - The patient is referred for PR at the UHL. - Male or female, aged 40+ years - Able to communicate in written and spoken English Exclusion Criteria: - Unable to provide valid informed consent. - Lack of motivation to participate in PR programme. - Any-contra-indications absolute or relative to exercise training. - Has had a cardiac event within last 6 weeks - Severe psychiatric disorders - Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend). - Aged less than 40 years - Unable to understand written or spoken English. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | NIHR Leicester Biomedical Research Centre - Respiratory | Leicester | Leicestershire |
Lead Sponsor | Collaborator |
---|---|
University of Leicester |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Phase 1 - Semi-structured Interviews | Semi-structured interview with individuals with COPD | 30-45 minutes | |
Primary | Phase 2 - Differences between time spent in PA intensity expressed in absolute and relative intensity. | Differences between time spent in PA intensity expressed in absolute and relative using activity monitors (wrist and waist) for eight days before and after the PR programme. | 8 days | |
Secondary | Phase 1 - Medical Research Council (MRC) Dyspnoea Scale | Medical Research Council (MRC) Dyspnoea Scale Minimum value: 1 Maximum value: 5 The higher the score, the worse the outcome (breathlessness). | 2 minutes | |
Secondary | Phase 1 - COPD Assessment Test (CAT) | COPD Assessment Test (CAT) | 5 minutes | |
Secondary | Phase 1 - Chronic Respiratory Questionnaire (CRQ-SR) | Chronic Respiratory Questionnaire (CRQ-SR) | 5 minutes | |
Secondary | Phase 1 - Photovoice and photo-elicitation | Photovoice is a qualitative research method that focuses on participants identifying and addressing important topics that matter to them through photography. This will gain greater insight from the participants about their experiences of participating in PA. Participant-generated images will be used to inform the photo-elicitation aspect of the interview to enable participants to capture in real time, more graphically illustrate their experiences and perceptions of different types of PA. | 7 days | |
Secondary | Phase 2 - Medical Research Council (MRC) Dyspnoea Scale | Medical Research Council (MRC) Dyspnoea Scale | 2 minutes | |
Secondary | Phase 2 - COPD Assessment Test (CAT) | COPD Assessment Test (CAT) | 5 minutes | |
Secondary | Phase 2 - Chronic Respiratory Questionnaire (CRQ-SR) | Chronic Respiratory Questionnaire (CRQ-SR) | 5 minutes | |
Secondary | Phase 2 - Gait Analysis | Gait Analysis - Speed, Variability, Asymmetry | 45 minutes | |
Secondary | Phase 2 - Exercise Capacity (ISWT) | Incremental Shuttle Walk Test | 30-45 minutes | |
Secondary | Phase 2 - Exercise Capacity (ESWT) | Endurance Shuttle Walk Test | 15-30 minutes | |
Secondary | Daily PROactive Physical Activity instrument in COPD (D-PPAC) | Daily PROactive Physical Activity instrument in COPD (D-PPAC) | 5 minutes | |
Secondary | Phase 2 - Photovoice and photo-elicitation | Photovoice is a qualitative research method that focuses on participants identifying and addressing important topics that matter to them through photography. This will gain greater insight from the participants about their experiences of participating in PA. Participant-generated images will be used to inform the photo-elicitation aspect of the interview to enable participants to capture in real time, more graphically illustrate their experiences and perceptions of different types of PA. | 8 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|